±¹³»µµ¼
Àü°øµµ¼/´ëÇб³Àç
ÀǾàÇа£È£°è¿
Á¤°¡ |
28,000¿ø |
---|
25,200¿ø (10%ÇÒÀÎ)
280P (1%Àû¸³)
ÇÒÀÎÇýÅÃ | |
---|---|
Àû¸³ÇýÅà |
|
|
|
Ãß°¡ÇýÅÃ |
|
À̺¥Æ®/±âȹÀü
¿¬°üµµ¼
»óÇ°±Ç
ÀÌ»óÇ°ÀÇ ºÐ·ù
Ã¥¼Ò°³
¢º ÀÌ Ã¥Àº ½ÉÇ÷°üÁßÀç½Ã¼ú½Ç °£È£ ÁöħÀ» ´Ù·é À̷мÀÔ´Ï´Ù.
¸ñÂ÷
I. ÀÌ·Ð(Basic): ½ÉÇ÷°ü°è ÁúȯÀÇ Àü¹ÝÀû ÀÌÇØ
1. ½ÉÀå ¹× °ü»óµ¿¸Æ Ç÷°üÀÇ ÇغÎÇÐÀû ±¸Á¶¿Í ±â´É/1
1.1. ½ÉÀåÀÇ ÇغÎÇÐÀû ±¸Á¶¿Í ±â´É 2
1.2. °ü»óµ¿¸ÆÀÇ ÇغÎÇÐÀû ±¸Á¶ 4
2. ÇãÇ÷¼º ½ÉÀåÁúȯ(Ischemic Heart Disease)ÀÇ ÀÌÇØ/7
2.1. ÇãÇ÷¼º ½ÉÀåÁúȯ(IHD: Ischemic Heart Disease) 8
2.2. ¾ÈÁ¤Çü Çù½ÉÁõ(Stable Angina)ÀÇ Áø´Ü°ú Ä¡·á 11
2.3. ±Þ¼º °ü»óµ¿¸Æ ÁõÈıº(ACS: Acute Coronary Syndrome)ÀÇ Á¤ÀÇ ¹× º´Å»ý¸® 14
2.4. ±Þ¼º ½É±Ù°æ»ö(AMI: Acute Myocardial Infarction)ÀÇ º´Å»ý¸®, EKG ¹× Ä¡·á
2.5. ÇãÇ÷¼º ½ÉÀåÁúȯ ȯÀÚÀÇ ¾à¹°Ä¡·á 21
2.6. ÇãÇ÷¼º ½ÉÀåÁúȯ ȯÀÚÀÇ °ü»óµ¿¸Æ ÁßÀç¼ú°ú °ü»óµ¿¸Æ ¿ìȸ¼ú 23
3. Other Heart Disease¿¡ ´ëÇÑ ÀÌÇØ/25
3.1. ½ÉºÎÀü(Heart Failure) 26
3.2. ½É±Ùº´Áõ(Cardiomyopathy) 28
3.3. ½ÉÀåÆǸ· Áúȯ(Valvular Heart Disease) 29
3.4. ºÎÁ¤¸Æ(Arrhythmia) 34
3.5. °¨¿°¼º ½É³»¸·¿°(Infective Endocarditis) 35
3.6. ½É¸·Áúȯ(Pericardial Disease) 35
3.7. ½ÉÀå Á¾¾ç(Cardiac Tumors) 36
3.8. ½É¹æ Áß°Ý °á¼Õ(ASD: Atrial Septal Defect) 37
3.9. µ¿¸Æ°ü °³Á¸Áõ(PDA: Patent Ductus Arteriosus) 39
3.10. ³¿ø°ø °³Á¸Áõ(PFO: Patent Foramen Ovale) 40
3.11. Æóµ¿¸Æ ÇùÂøÁõ(PS: Pulmonary Stenosis) 41
3.12. Á½ɹæÀÌ(LAA: Left Atrial Appendage) 44
3.13. Æó°íÇ÷¾Ð(Pulmonary Hypertension) 46
3.14. Æóµ¿¸Æ °íÇ÷¾Ð(Pulmonary Arterial Hypertension) 49
3.15. ¸¸¼º Ç÷Àü»öÀü¼º Æó°íÇ÷¾Ð(CTEPH)51
3.16. ÁßÁõ ´ëµ¿¸ÆÆǸ· ÇùÂøÁõ(Severe Aortic Valve Stenosis) 54
4. ÇãÇ÷¼º ½ÉÀå Áúȯ(Ischemic Heart Disease)ÀÇ Áø´Ü °Ë»ç/59
4.1 ½ÉÀüµµ(ECG/EKG: Electrocardiography) 60
4.2. ½ÉÃÊÀ½ÆÄ(Echo: Echocardiography) 64
4.3. ¿îµ¿ºÎÇÏ °Ë»ç(TMT: Treadmill Test) 68
4.4. ¿îµ¿ºÎÇÏ ½ÉÆó±â´É °Ë»ç(CPX: Cardiopulmonary Exercise Test) 70
4.5. ½É±Ù°ü·ù °Ë»ç(MIBI SPECT) 72
4.6. ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CT: Computer Tomography) 74
4.7. °ü»óµ¿¸Æ Á¶¿µ¼ú(Coronary Angiography) 76
II. ¼öÇà: ½ÉÇ÷°üÁßÀç½Ã¼ú½Ç¿¡¼ ÀÌ·ç¾îÁö´Â ½Ã¼ú ¹× ȯÀÚ °£È£
1. ½ÉÇ÷°üÁßÀç½Ã¼ú½Ç¿¡¼ ÀÌ·ç¾îÁö´Â ½Ã¼ú ¹× °Ë»ç¿Í °£È£/89
1.1. °ü»óµ¿¸Æ Á¶¿µ¼ú(Coronary Angiography) 91
1.2. °ü»óµ¿¸Æ ÁßÀç½Ã¼ú(PCI: Percutaneus Coronary Intervention) 92
1.3. ȸÀüÁ×»ó¹ÝÀýÁ¦¼ú(Rotational Atherectomy) 92
1.4. Ç÷°ü°æ·Ã À¯¹ß°Ë»ç(Provocation Test) 93
1.5. ½ÉµµÀÚ¼ú(Cardiac Catheterization) 94
1.6. °æÇÇÀû ½Â¸ðÆÇÈ®À强Çü¼ú(PMV: Percutaneous Mitral Valvuloplasty) 95
1.7. ½É³¶ õÀÚ(Pericardiocentesis) 96
1.8. ½É±Ù »ý°Ë(Cardiac Biopsy) 96
1.9. ½É¹æÁß°Ý°á¼Õ Æó»ö¼ú(ASD Occlusion Artrial Septal Defect Occlusion) 97
1.10. µ¿¸Æ°ü°³Á¸Áõ Æó»ö¼ú(PDA Occlusion: Patent Ductus Arteriosus Occlusion) 98
1.11. ³¿ø°ø Æó»ö¼ú(PFO Closure: Patent Foramen Ovale Closure) 99
1.12. Á½ɹæÀÌ Æó»ö¼ú(LAA Occlusion: Left Atrial Appendage Occlusion) 100
1.13. ¸¸¼º Ç÷Àü»öÀü¼º Æó°íÇ÷¾Ð & Æóµ¿¸Æ Ç³¼±¼ºÇü¼ú(CTEPH & BPA) 101
1.14. °æÇÇÀû ´ëµ¿¸Æ ÆǸ· »ðÀÔ¼ú(TAVI)102
1.15. ½É¹æ dz¼±Áß°ÝÀý°³¼ú(Atrial Balloon Septostomy) 103
1.16. °æÇÇÀû ÁÂ½É¹æ ¹è¾×¼ú(Percutaneous Transseptal Left Atrial Drainage) 104
2. ½ÉÇ÷°üÁßÀç½Ã¼ú½Ç¿¡¼ ÀÌ·ç¾îÁö´Â º¸Á¶Àû ½Ã¼ú ¹× °Ë»ç
2.1. °æÇÇÀû ½ÉÆóü¿Ü¼øȯ(PCPS: Percutaneous Cardio Pulmonary Support) 108
2.2. ´ëµ¿¸Æ ³» dz¼± ÆßÇÁ(IABP: Intra Aortic Balloon Pump) 115
2.3. ÀϽÃÀû Àΰø ½É¹Úµ¿±â(Temporary Pacemaker) 118
2.4. Swan-Ganz catheter 120
2.5. Ç÷°ü ³» ÃÊÀ½ÆÄ(IVUS: Intravascular Ultrasound) 123
2.6. °¡»óÁ¶Á÷ Ç÷°ü ³» ÃÊÀ½ÆÄ(VH-IVUS) 127
2.7. ±¤°£¼· ´ÜÃþÃÔ¿µ(OCT: Optical Coherence Tomography)128
2.8. ½É±Ù ºÐȹ Ç÷·ù ¿¹ºñ·Â(FFR: Fractional Flow Reserve) 130
3. ½ÉÇ÷°üÁßÀç½Ã¼ú½Ç¿¡¼ »ç¿ëµÇ´Â ¾à¹°
3.1. ¼¼ºê¶õ½º ½ÉÀåÇ÷°üº´¿ø ÁßÀç½Ã¼ú½Ç E-box ¾à¹° 136
1) Amiodarone HCl(150mg/3mL/A) 137
2) Atropine Sulfate(0.5mg/1mL/A) 137
3) CaCl2 3%(600mg/20mL/A) 138
4) Dopamine HCl(200mg/5mL/A) 138
5) Dopamine HCl 400mg+5% DW 200mL/bag 138
6) Dobutamine HCl 500mg+5% DW 250mL/bag 139
7) Epinephrine HCl(1mg/1mL/A) 139
8) Furosemide(20mg/2mL/A) 139
9) Hydrocortisone Na Succinate(100mg/V) 140
10) Methylprednisolone Na Succinate(125mg/V) 140
11) Norepinephrine(4mg/4mL/A) 140
12) Vecuronium Bromide(4mg/V) 141
13) Magnesium Sulfate(2g/20mL/A) 141
14) Sodium bicarbonate(20mEq/20mL/A) 141
15) Dextrose 20% 142
16) Lidocaine HCl 1%(200mg/20mL/V) 142
17) Lidocaine HCl 4%(°æ¸·¿Ü)(800mg/20mL/V) 142
3.2. ¼¼ºê¶õ½º ½ÉÇ÷°üº´¿ø ÁßÀç½Ã¼ú½Ç ºñÇ°¾à 143
1) Digoxin(0.25mg/1mL/A) 143
2) Aminophylline(250mg/10mL/A) 143
3) Nitroglycerin(10mg/10mL/A) 143
4) Protamine Sulfate(50mg/5mL/A) 144
5) Adenosine(6mg/2mL/V) 144
6) Dexamethasone(5mg/1mL/A) 145
7) Nitroglycerin(0.6mg/T) 146
8) Metoclopramide HCl(10mg/2mL/A) 146
9) Tramadol HCl(50mg/1mL/A) 147
10) Vitamin K1(=Phytonadione)(10mg/1mL/A) 147
11) Chlorpheniramine maleate(4mg/2mL/A) 147
12) 6% Volulyte Inj 500mg/bag 148
13) Flumazenil(0.5mg/5mL/A) 148
3.3. ±× ¿Ü ½ÉÇ÷°üÁßÀç½Ã¼ú½Ç¿¡¼ Intra Coronary Artery·Î Åõ¿©µÇ´Â ¾à¹° 149
1) Nicorandil(48mg/V) 149
3.4. Ç×Ç÷¼ÒÆÇÁ¦, Ç×ÀÀ°íÁ¦, Ç×Ç÷ÀüÁ¦ ¾à¹° 149
1) Aspirin/Astrix(Ç×Ç÷¼ÒÆÇÁ¦) 149
2) Plavix, Platless, Plavitor(Ç×Ç÷¼ÒÆÇÁ¦) 150
3) Brilinta(Ç×Ç÷¼ÒÆÇÁ¦) 150
4) Effient(Ç×Ç÷¼ÒÆÇÁ¦) 151
5) Clotinab inj(Ç×Ç÷¼ÒÆÇÁ¦) 151
6) Heparin(Ç×ÀÀ°íÁ¦) 152
7) Clexane(Ç×ÀÀ°íÁ¦) 152
8) Urokinase inj(Ç×Ç÷ÀüÁ¦) 153
4. ½ÉÇ÷°üÁßÀç½Ã¼ú½Ç¿¡¼ ¹ß»ý °¡´ÉÇÑ ÇÕº´Áõ ¹× °£È£/155
4.1. PCI ½Ã ¹ß»ý °¡´ÉÇÑ ÇÕº´Áõ(Complications) 156
1) °ü»óµ¿¸Æ ¹Ú¸®(Coronary Artery Dissection) 156
2) ±Þ¼º °ü»óµ¿¸Æ Æó¼â(Acute Closure) 157
3) ¹«Àç°ü·ù(No-reflow Phenomenon) 158
4) °ü»óµ¿¸Æ õ°ø/ÆÄ¿(Coronary Perforation/Rupture) 158
5) »ç¸Á(Death) 160
4.2. Local Vascular Complications 160
1) ±¹¼Ò ÃâÇ÷°ú Ç÷Á¾(Bleeding and Hematoma) 160
2) ±¸È¹ÁõÈıº(Compartment Syndrome) 160
3) µ¿Á¤¸Æ·ç(A-V Fistula) 160
4) °¡µ¿¸Æ·ù(Pseudoaneurysm) 160
5) ±âŸ 161
6) ´ëÅðµ¿¸Æ ÃµÀÚ À§Ä¡¿¡ µû¶ó ¹ß»ý °¡´ÉÇÑ ÇÕº´Áõ 161
7) ÇÕº´Áõ¿¡ µû¸¥ °£È£ 161
4.3. Medical Complications: Side Effect of Contrast 161
III. ¾÷¹«(Task): ½ÉÇ÷°üÁßÀç½Ã¼ú½Ç °£È£»çÀÇ ¾÷¹«
1. ½ÉÇ÷°üÁßÀç½Ã¼ú½Ç °£È£/165
1.1. ½ÉÇ÷°üÁßÀç½Ã¼ú½Ç ÀÏ¹Ý °£È£ 166
1) °Ë»ç Àü °£È£(°Ë»ç ´ë±â Áß) 166
2) °Ë»ç Áß °£È£(°Ë»ç½Ç ÀÔ½Ç ½Ã) 166
3) °Ë»ç ÈÄ °£È£ 167
1.2. ÀÀ±Þ»óȲ ½Ã °£È£ 170
1) ¼öÇ÷°£È£ 170
2) Anaphylactic Shock 174
3) ½ÉÀμº ¼îÅ©(Cardiogenic Shock) 176
4) FIRST 176
5) Arrest »óȲ ½Ã ¿ªÇÒ ºÐ´ã 178
2. ½ÉÇ÷°üÁßÀç½Ã¼ú½Ç ±Þ¿© ¹× ºñ±Þ¿© ¼ö°¡ »êÁ¤ ½É»ç/178
1.1. ¼ö°¡ »êÁ¤ÀÇ ÀÏ¹Ý ¿øÄ¢ 178
1.2. ±Þ¿©¿Í ºñ±Þ¿© ó¹æ(¼¼ºê¶õ½º ½ÉÀåÇ÷°üº´¿ø ÁßÀç½Ã¼ú½Ç ÇöȲ) 181
3. EMR ±â·Ï ÀÛ¼º/194
1.1. Coronary Angiography °á°úÁö ÀÛ¼º 194
1.2. °£È£±â·Ï 194
4. º´½Ç ¹èÁ¤ ¹× À̵¿/195
1.1. ÀϹÝÀû ¿øÄ¥ 195
1.2. ÃÊÁøȯÀÚ ÀÀ±Þ Àü¿ø°úÁ¤ 196
1.3. ȯÀÚÀÌ¼Û ¹æ¹ý 196
ÁÖ°£·©Å·
´õº¸±â»óÇ°Á¤º¸Á¦°ø°í½Ã
À̺¥Æ® ±âȹÀü
Àü°øµµ¼/´ëÇб³Àç ºÐ¾ß¿¡¼ ¸¹Àº ȸ¿øÀÌ ±¸¸ÅÇÑ Ã¥
ÆǸÅÀÚÁ¤º¸
»óÈ£ |
(ÁÖ)±³º¸¹®°í |
---|---|
´ëÇ¥ÀÚ¸í |
¾Èº´Çö |
»ç¾÷ÀÚµî·Ï¹øÈ£ |
102-81-11670 |
¿¬¶ôó |
1544-1900 |
ÀüÀÚ¿ìÆíÁÖ¼Ò |
callcenter@kyobobook.co.kr |
Åë½ÅÆǸž÷½Å°í¹øÈ£ |
01-0653 |
¿µ¾÷¼ÒÀçÁö |
¼¿ïƯº°½Ã Á¾·Î±¸ Á¾·Î 1(Á¾·Î1°¡,±³º¸ºôµù) |
±³È¯/ȯºÒ
¹ÝÇ°/±³È¯ ¹æ¹ý |
¡®¸¶ÀÌÆäÀÌÁö > Ãë¼Ò/¹ÝÇ°/±³È¯/ȯºÒ¡¯ ¿¡¼ ½Åû ¶Ç´Â 1:1 ¹®ÀÇ °Ô½ÃÆÇ ¹× °í°´¼¾ÅÍ(1577-2555)¿¡¼ ½Åû °¡´É |
---|---|
¹ÝÇ°/±³È¯°¡´É ±â°£ |
º¯½É ¹ÝÇ°ÀÇ °æ¿ì Ãâ°í¿Ï·á ÈÄ 6ÀÏ(¿µ¾÷ÀÏ ±âÁØ) À̳»±îÁö¸¸ °¡´É |
¹ÝÇ°/±³È¯ ºñ¿ë |
º¯½É ȤÀº ±¸¸ÅÂø¿À·Î ÀÎÇÑ ¹ÝÇ°/±³È¯Àº ¹Ý¼Û·á °í°´ ºÎ´ã |
¹ÝÇ°/±³È¯ ºÒ°¡ »çÀ¯ |
·¼ÒºñÀÚÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¼Õ½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì ·¼ÒºñÀÚÀÇ »ç¿ë, Æ÷Àå °³ºÀ¿¡ ÀÇÇØ »óÇ° µîÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì ·º¹Á¦°¡ °¡´ÉÇÑ »óÇ° µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì ·½Ã°£ÀÇ °æ°ú¿¡ ÀÇÇØ ÀçÆǸŰ¡ °ï¶õÇÑ Á¤µµ·Î °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì ·ÀüÀÚ»ó°Å·¡ µî¿¡¼ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·üÀÌ Á¤ÇÏ´Â ¼ÒºñÀÚ Ã»¾àöȸ Á¦ÇÑ ³»¿ë¿¡ ÇØ´çµÇ´Â °æ¿ì |
»óÇ° Ç°Àý |
°ø±Þ»ç(ÃâÆÇ»ç) Àç°í »çÁ¤¿¡ ÀÇÇØ Ç°Àý/Áö¿¬µÉ ¼ö ÀÖÀ½ |
¼ÒºñÀÚ ÇÇÇغ¸»ó |
·»óÇ°ÀÇ ºÒ·®¿¡ ÀÇÇÑ ±³È¯, A/S, ȯºÒ, Ç°Áúº¸Áõ ¹× ÇÇÇغ¸»ó µî¿¡ °üÇÑ »çÇ×Àº¼ÒºñÀÚºÐÀïÇØ°á ±âÁØ (°øÁ¤°Å·¡À§¿øȸ °í½Ã)¿¡ ÁØÇÏ¿© ó¸®µÊ ·´ë±Ý ȯºÒ ¹× ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó±Ý Áö±Þ Á¶°Ç, ÀýÂ÷ µîÀº ÀüÀÚ»ó°Å·¡ µî¿¡¼ÀǼҺñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ µû¶ó ó¸®ÇÔ |
(ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º´Â ȸ¿ø´ÔµéÀÇ ¾ÈÀü°Å·¡¸¦ À§ÇØ ±¸¸Å±Ý¾×, °áÁ¦¼ö´Ü¿¡ »ó°ü¾øÀÌ (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º¸¦ ÅëÇÑ ¸ðµç °Å·¡¿¡ ´ëÇÏ¿©
(ÁÖ)KGÀ̴Ͻýº°¡ Á¦°øÇÏ´Â ±¸¸Å¾ÈÀü¼ºñ½º¸¦ Àû¿ëÇÏ°í ÀÖ½À´Ï´Ù.
¹è¼Û¾È³»
±³º¸¹®°í »óÇ°Àº Åùè·Î ¹è¼ÛµÇ¸ç, Ãâ°í¿Ï·á 1~2Àϳ» »óÇ°À» ¹Þ¾Æ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
Ãâ°í°¡´É ½Ã°£ÀÌ ¼·Î ´Ù¸¥ »óÇ°À» ÇÔ²² ÁÖ¹®ÇÒ °æ¿ì Ãâ°í°¡´É ½Ã°£ÀÌ °¡Àå ±ä »óÇ°À» ±âÁØÀ¸·Î ¹è¼ÛµË´Ï´Ù.
±ººÎ´ë, ±³µµ¼Ò µî ƯÁ¤±â°üÀº ¿ìü±¹ Åù踸 ¹è¼Û°¡´ÉÇÕ´Ï´Ù.
¹è¼Ûºñ´Â ¾÷ü ¹è¼Ûºñ Á¤Ã¥¿¡ µû¸¨´Ï´Ù.